<DOC>
	<DOCNO>NCT03060434</DOCNO>
	<brief_summary>The objective prospective control crossover study evaluate efficacy safety pentoxifylline per o ( 800 mg daily ) management lumbar radiculopathy</brief_summary>
	<brief_title>Pentoxifylline Lumbar Radiculopathy</brief_title>
	<detailed_description>Patients lumbar radiculopathy , recruit senior author clinic . After verification inclusion exclusion criterion , patient consent enter study give 2 sequence ( order randomly assign ) treatment : Ibuprofen 600 mg bid , paracetamol 1000 mg tid , pregabalin 75 mg bid 15 day pentoxifylline 15 day without . Basic clinical demographical data note . Lumbar MRI result also note . Clinical evaluation patient perform include : clinical examination ( include motor exam low limb ) ; pain assess accord Numerical rating Scale ( NRS ) , relative percentage global improvement .</detailed_description>
	<mesh_term>Radiculopathy</mesh_term>
	<mesh_term>Intervertebral Disc Displacement</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Unilateral lumbar radiculopathy Disc hernia confirm diagnosis radioclinical concordance Radicular deficit need surgery Cauda equine syndrome Absence radioclinical concordance MRI Contraindication antiinflammatory ( Hypertension , renal insufficiency , gastric ulcer â€¦ ) Previous intolerance pentoxifylline , and/or pregabalin and/or paracetamol Pregnancy Followup possible Hepatic dysfunction History drug abuse Current use tramadol , codeine and/or morphine derivative Antidepressant use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>pentoxifylline</keyword>
	<keyword>Disc hernia</keyword>
	<keyword>sciatica</keyword>
	<keyword>lumbar radiculopathy</keyword>
</DOC>